NCT07147465View on ClinicalTrials.gov

Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for Oncology Patients

RecruitingOBSERVATIONAL

Enrollment

3,149

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

September 30, 2026

Conditions

CancerNGSTumorRARE DISEASE

Trial Locations (3)

69000

RECRUITING

Centre Leon Berard, Lyon

75004

ACTIVE_NOT_RECRUITING

APHP Hôtel Dieu URC Economie de la sante /URC ECO, Paris

75005

RECRUITING

HOPITAL AP-HP Cochin, Paris

Sponsors

Collaborators (1)

Laboratoire SeqOIA

All Listed Sponsors

collaborator

AuraGen Aesthetics LLC

INDUSTRY

collaborator

Centre Leon Berard

OTHER

collaborator

Laboratoire SeqOIA

UNKNOWN

collaborator

PLAN FRANCE MÉDECINE GÉNOMIQUE 2025

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT07147465 - Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for Oncology Patients | Biotech Hunter | Biotech Hunter